RS49628B - Medicinski aerosolni proizvodi - Google Patents
Medicinski aerosolni proizvodiInfo
- Publication number
- RS49628B RS49628B YUP-598/99A YU59899A RS49628B RS 49628 B RS49628 B RS 49628B YU 59899 A YU59899 A YU 59899A RS 49628 B RS49628 B RS 49628B
- Authority
- RS
- Serbia
- Prior art keywords
- aerosol products
- medicinal aerosol
- butyl
- formula
- heptafluoropropane
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical group FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- -1 isobutanoyl group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Materials For Medical Uses (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Farmaceutska kompozicija koja sadrži terapeutski efikasnu količinu jedinjenja Formule: (I) u kojoj: R1 jeste 1-butil, 2-butil, cikloheksil ili fenil, a R2 je acetil ili izobutanoil grupa, i propelent odabran između 1,1,1,2-tetrafluoroetana, 1,1,1,2,3,3,3-heptafluoropropana i njihove smeše, i etanol u količini efikasnoj da rastvori jedinejnje formule (I) i, u datom slučaju, površinski aktivnu supstancu. Prijava sadrži još 1 nezavisan zahtev i 15 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710496.2A GB9710496D0 (en) | 1997-05-21 | 1997-05-21 | Medicinal aerosol products |
GBGB9803990.2A GB9803990D0 (en) | 1998-02-25 | 1998-02-25 | Medicinal aerosol products |
Publications (2)
Publication Number | Publication Date |
---|---|
YU59899A YU59899A (sh) | 2002-06-19 |
RS49628B true RS49628B (sr) | 2007-08-03 |
Family
ID=26311564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-598/99A RS49628B (sr) | 1997-05-21 | 1998-05-18 | Medicinski aerosolni proizvodi |
Country Status (28)
Country | Link |
---|---|
US (1) | US6120752A (sr) |
EP (1) | EP0983058B1 (sr) |
JP (4) | JP2001526685A (sr) |
KR (1) | KR100527643B1 (sr) |
CN (1) | CN1149073C (sr) |
AT (1) | ATE245966T1 (sr) |
AU (1) | AU726835B2 (sr) |
BG (1) | BG64268B1 (sr) |
BR (1) | BR9809448A (sr) |
CA (1) | CA2290521C (sr) |
CZ (1) | CZ298253B6 (sr) |
DE (1) | DE69816811T2 (sr) |
DK (1) | DK0983058T3 (sr) |
EA (1) | EA002381B1 (sr) |
ES (1) | ES2205491T3 (sr) |
HK (1) | HK1027027A1 (sr) |
HU (1) | HU226694B1 (sr) |
IL (1) | IL132738A (sr) |
ME (1) | ME01631B (sr) |
NO (2) | NO327716B1 (sr) |
NZ (1) | NZ500874A (sr) |
PL (1) | PL191523B1 (sr) |
PT (1) | PT983058E (sr) |
RS (1) | RS49628B (sr) |
SK (1) | SK283930B6 (sr) |
TR (1) | TR199902863T2 (sr) |
UA (1) | UA58551C2 (sr) |
WO (1) | WO1998052542A1 (sr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
US6315985B1 (en) | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
AR026073A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
GB0002798D0 (en) * | 2000-02-09 | 2000-03-29 | Glaxo Group Ltd | Actuator nozzle for metered dose inhaler |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
WO2004033478A2 (en) * | 2002-10-08 | 2004-04-22 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
DK3170880T3 (da) * | 2002-10-25 | 2020-07-06 | Honeywell Int Inc | Anvendelse af sammensætninger, der omfatter hfo-1234ze eller hfo-1234yf som kølemiddelsammensætning |
DK1572217T3 (da) * | 2002-12-12 | 2008-12-15 | Nycomed Gmbh | Kombinationsmedikament af R,R-formoterol og ciclesonid |
MY143936A (en) * | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
WO2004103379A1 (en) * | 2003-05-22 | 2004-12-02 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
WO2004110460A1 (en) * | 2003-06-13 | 2004-12-23 | Altana Pharma Ag | Formoterol and ciclesonide combination |
ES2452691T5 (es) * | 2003-09-16 | 2022-09-14 | Covis Pharma Gmbh | Uso de ciclesonida para el tratamiento de enfermedades respiratorias |
GB2406283B (en) | 2003-09-24 | 2006-04-05 | Altana Pharma Ag | Compliance monitor and method |
US9308199B2 (en) | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
AR041873A1 (es) * | 2003-10-30 | 2005-06-01 | Pablo Cassara Srl Lab | Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
WO2005065185A2 (en) * | 2003-12-24 | 2005-07-21 | Collegium Pharmaceuticals, Inc. | Temperature-stable formulations, and methods of development thereof |
JP2007533706A (ja) * | 2004-04-20 | 2007-11-22 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 |
JP2008512428A (ja) * | 2004-09-10 | 2008-04-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクレソニドとSykインヒビターとの組合せ物並びにその使用方法 |
JP2008546634A (ja) * | 2005-03-16 | 2008-12-25 | ハネウェル・インターナショナル・インコーポレーテッド | 医薬送達製剤、デバイス及び方法 |
WO2007068007A1 (en) * | 2005-12-07 | 2007-06-14 | Harm Benjamin Steyn | Use of a disinfectant for treating respiratory tract infections |
ES2691033T3 (es) | 2007-02-11 | 2018-11-23 | Map Pharmaceuticals Inc. | Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios |
US20100120737A1 (en) * | 2008-11-10 | 2010-05-13 | Martin Feth | Amorphous ciclesonide |
CN102348714B (zh) * | 2009-03-09 | 2015-01-07 | 三笠制药株式会社 | 甾族化合物 |
WO2011135585A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
MX2013004137A (es) * | 2010-10-12 | 2013-07-29 | Cipla Ltd | Composicion farmaceutica. |
AU2012296880A1 (en) | 2011-08-18 | 2014-03-27 | Astrazeneca Ab | Pharmaceutical aerosol product for administration by oral or nasal inhalation |
CN102335132A (zh) * | 2011-10-12 | 2012-02-01 | 中山大学 | 一种细辛脑吸入气雾剂及其制备方法 |
US9603906B2 (en) | 2012-02-01 | 2017-03-28 | Protalix Ltd. | Inhalable liquid formulations of DNase I |
US20170304459A1 (en) | 2014-10-10 | 2017-10-26 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2077229B (en) * | 1980-05-16 | 1983-08-03 | Neotechnic Eng Ltd | Valve assembly for a pressurized aerosoldispensing container |
GB8824804D0 (en) * | 1988-10-22 | 1988-11-30 | Fisons Plc | Device |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8900267D0 (en) * | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
GB8921222D0 (en) * | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
IE67185B1 (en) * | 1990-02-02 | 1996-03-06 | Fisons Plc | Propellant compositions |
DE4003272A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
WO1991014422A1 (en) * | 1990-03-23 | 1991-10-03 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
DE69105212T2 (de) * | 1990-10-18 | 1995-03-23 | Minnesota Mining And Mfg. Co., Saint Paul, Minn. | Aerosolzubereitung, die beclometason 17,21-dipropionat enthält. |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
US5683676A (en) * | 1991-12-12 | 1997-11-04 | Glaxo Group Limited | Canister containing aerosol formulations containing P134a and particulate medicaments |
US5474758A (en) * | 1993-07-28 | 1995-12-12 | Minnesota Mining And Manufacturing Company | Seals for use in an aerosol delivery device |
DK0735884T3 (da) * | 1993-12-20 | 2000-10-09 | Minnesota Mining & Mfg | Flunisolid-aerosolformuleringer |
DE19541689A1 (de) * | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
US5653961A (en) * | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
KR19980703850A (ko) * | 1995-04-14 | 1998-12-05 | 그레이엄브레레톤 | 베클로메타손 디프로피오네이트용 계량 흡입기 |
EP0820323B1 (en) * | 1995-04-14 | 2003-09-24 | SmithKline Beecham Corporation | Metered dose inhaler for salmeterol |
SI0820279T1 (en) * | 1995-04-14 | 2002-12-31 | Smithkline Beecham Corporation | Metered dose inhaler for albuterol |
-
1998
- 1998-05-13 US US09/076,958 patent/US6120752A/en not_active Expired - Lifetime
- 1998-05-18 BR BR9809448-3A patent/BR9809448A/pt not_active Application Discontinuation
- 1998-05-18 IL IL13273898A patent/IL132738A/en not_active IP Right Cessation
- 1998-05-18 WO PCT/US1998/010155 patent/WO1998052542A1/en active IP Right Grant
- 1998-05-18 JP JP55049498A patent/JP2001526685A/ja active Pending
- 1998-05-18 CZ CZ0412499A patent/CZ298253B6/cs not_active IP Right Cessation
- 1998-05-18 PT PT98922409T patent/PT983058E/pt unknown
- 1998-05-18 KR KR10-1999-7010773A patent/KR100527643B1/ko active IP Right Grant
- 1998-05-18 CN CNB98805261XA patent/CN1149073C/zh not_active Expired - Lifetime
- 1998-05-18 AT AT98922409T patent/ATE245966T1/de active
- 1998-05-18 DE DE69816811T patent/DE69816811T2/de not_active Expired - Lifetime
- 1998-05-18 AU AU74962/98A patent/AU726835B2/en not_active Expired
- 1998-05-18 ES ES98922409T patent/ES2205491T3/es not_active Expired - Lifetime
- 1998-05-18 SK SK1576-99A patent/SK283930B6/sk not_active IP Right Cessation
- 1998-05-18 DK DK98922409T patent/DK0983058T3/da active
- 1998-05-18 CA CA002290521A patent/CA2290521C/en not_active Expired - Lifetime
- 1998-05-18 UA UA99116244A patent/UA58551C2/uk unknown
- 1998-05-18 EA EA199900991A patent/EA002381B1/ru not_active IP Right Cessation
- 1998-05-18 RS YUP-598/99A patent/RS49628B/sr unknown
- 1998-05-18 ME MEP-1999-598A patent/ME01631B/me unknown
- 1998-05-18 HU HU0002691A patent/HU226694B1/hu active Protection Beyond IP Right Term
- 1998-05-18 PL PL336885A patent/PL191523B1/pl unknown
- 1998-05-18 EP EP98922409A patent/EP0983058B1/en not_active Expired - Lifetime
- 1998-05-18 TR TR1999/02863T patent/TR199902863T2/xx unknown
- 1998-05-18 NZ NZ500874A patent/NZ500874A/en not_active IP Right Cessation
-
1999
- 1999-11-18 NO NO995667A patent/NO327716B1/no not_active IP Right Cessation
- 1999-11-19 BG BG103902A patent/BG64268B1/bg unknown
-
2000
- 2000-08-30 HK HK00105446A patent/HK1027027A1/xx not_active IP Right Cessation
-
2009
- 2009-10-26 NO NO2009024C patent/NO2009024I2/no unknown
-
2010
- 2010-12-03 JP JP2010270854A patent/JP2011102301A/ja not_active Withdrawn
-
2014
- 2014-09-16 JP JP2014187710A patent/JP6087882B2/ja not_active Expired - Lifetime
-
2016
- 2016-05-19 JP JP2016100499A patent/JP6178459B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49628B (sr) | Medicinski aerosolni proizvodi | |
CY1107899T1 (el) | 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας | |
ATE306261T1 (de) | Antithrombosemittel | |
YU11997A (sh) | Laktamski derivati i njihove farmaceutske kompozicije | |
EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
MEP24608A (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
IL133623A0 (en) | Antithrombotic agents | |
ATE229802T1 (de) | Zusammenstellung aus gemischten cyanoacrylatestern | |
EE200100558A (et) | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine | |
NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
YU56995A (sh) | Soli derivata indola | |
EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
RS50046B (sr) | Farmaceutske kompozicije tizoksanida i nitazoksanida | |
DK1303258T3 (da) | Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle | |
ATE401056T1 (de) | Formoterol und ciclesonid aerosol-formulierungen | |
YU41198A (sh) | Derivati pirolopirolona kao inhibitori neutrofilne elastaze | |
FI803264L (fi) | 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
ATE253359T1 (de) | Antithrombotische mittel | |
HUP0004058A2 (hu) | Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére | |
NO973401L (no) | Kortikosteroidinneholdende sammensetninger og fremstilling derav | |
EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
MX9306356A (es) | Composicion refrigerante que incluye bis(difluoro metil)eter. | |
KR950005929A (ko) | 탈지방지형 무취 네일 에나멜 리무버 조성물 | |
WO2000007580A3 (en) | Pharmaceutical compositions against autoimmune diseases | |
YU29299A (sh) | Steroidi supstituisani u položaju 11, postupak njihovog dobijanja, njihova primena kod lekova i farmaceutski preparati koji ih sadrže |